Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Taiwan Buddhist group enters fray for BioNTech COVID vaccines

Published 23/06/2021, 07:37
Updated 23/06/2021, 07:41
© Reuters.

TAIPEI (Reuters) - A major Taiwanese Buddhist group said on Wednesday that it was hoping to buy 5 million doses of BioNTech SE's COVID-19 vaccine, joining Foxconn and TSMC in trying to secure vaccines for the island.

Taiwan's government has millions of vaccines on order but has been hampered by global supply shortages, though Japan and the United States this month donated 3.74 million doses as the island deals with a cluster of domestic infections.

The Tzu Chi Foundation said that after "initial progress" had been made in sourcing the shots, it had submitted application documents to the government to be allowed to buy 5 million BioNTech doses.

Health Minister Chen Shih-chung said the government had received the documents and was reviewing them. He gave no details.

BioNTech did not immediately respond to a request for comment.

Taiwan's government said last week it would allow Terry Gou, the billionaire founder of Apple Inc (NASDAQ:AAPL) supplier Foxconn, and Taiwan Semiconductor Manufacturing Co Ltd to negotiate on its behalf for COVID-19 vaccines.

Both are proposing buying 5 million BioNTech doses each, to donate to the government.

The government says BioNTech told Gou it would only sell to governments.

Taiwan's own deal with BioNTech fell through this year, with the government blaming it on pressure from Beijing, though it says talks are continuing with the company.

China denied the accusation, saying Taiwan was free to obtain the vaccines through Shanghai Fosun Pharmaceutical Group Co Ltd, which has a contract with BioNTech to sell the vaccines in mainland China, Hong Kong, Macau and Taiwan.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Another Taiwanese group, the Buddha Light International Association, had proposed importing up to 500,000 shots of Johnson & Johnson (NYSE:JNJ)'s vaccine.

But the company said it was only negotiating with government bodies and supranational organisations like the European Commission for vaccine purchases.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.